a solid move would be nice but i see it 'flapping around in the breeze' until some news or excitment leading up to full year results.it is going to be a good year though and the patient will be rewarded.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025